EUDA Health (NASDAQ:EUDA) Lowered to “Strong Sell” Rating by Zacks Research

Zacks Research downgraded shares of EUDA Health (NASDAQ:EUDA) from a hold rating to a strong sell rating in a research report report published on Monday morning,Zacks.com reports.

A number of other research analysts have also recently issued reports on EUDA. Weiss Ratings reiterated a “sell (d)” rating on shares of EUDA Health in a research report on Friday, January 9th. Greenridge Global dropped their target price on shares of EUDA Health from $120.00 to $55.00 and set a “buy” rating for the company in a report on Monday, March 9th. One research analyst has rated the stock with a Buy rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Reduce” and a consensus price target of $55.00.

EUDA Health Stock Performance

EUDA Health stock opened at $9.13 on Monday. EUDA Health has a 52 week low of $6.42 and a 52 week high of $86.00. The stock has a market capitalization of $17.26 million, a P/E ratio of -76.08 and a beta of -0.11. The stock has a fifty day moving average of $19.87 and a 200-day moving average of $38.08.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in EUDA Health stock. Jane Street Group LLC acquired a new position in shares of EUDA Health Holdings Limited (NASDAQ:EUDA) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 25,675 shares of the company’s stock, valued at approximately $59,000. Jane Street Group LLC owned about 0.07% of EUDA Health as of its most recent SEC filing. 4.35% of the stock is currently owned by institutional investors.

About EUDA Health

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.